You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》A股三大指數回吐 創板全日低收跌逾2% 藥明康德跌停
內地首兩月出口按人民幣計按年增長10.3%,進口升6.7%;按美元計出口按年增長7.1%勝預期,進口升3.5%高於預期。人民銀行今日(7日)進行100億元人民幣(下同)七天期逆回購操作,中標利率持平於1.8%,單日淨回籠1,070億元。人民幣兌美元中間價上調14點,報7.1002。A股三大指數開市升跌不一,其後齊齊向下,午後跌幅擴大,創板跌超過2%。 滬綜指全日收報3,027點,跌12點或0.4%,成交4,234億元;深成指跌128點或1.4%,報9,267點,成交5,583億元。創業板指跌42點或2.3%,以低位收報1,789點,成交2,389億元。 中資金融股有支持,建行(601939.SH)及工行(601398.SH)各升0.6%。 全國政協經濟委員會副主任易綱建議設立房地產預售資金保險機制,內房股萬科(000002.SZ)、金地集團(600383.SH)及保利發展(600048.SH)跌0.8%至1.5%。 黃金相關股持續造好,山東黃金(600547.SH)再升3%。銀泰黃金(000975.SZ)更升4.3%。 比亞迪(002594.SZ)擬斥4億元回購至少148萬股A股,股價跌1.4%。此外,寧德時代(300750.SZ)跌2.1%。 藥明康德(603259.SH)跌停,美參議院委員會通過生物安全法案,藥明康德發聲明指公司不收集基因數據,該法案依靠誤導性指控及不準確的訊息,在未經正當程序的情況下對公司提出先發制人及不合理的禁令。(ta/cy) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account